Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
PET imaging in multiple sclerosis.
Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
The effectiveness of fingolimod in a Portuguese real-world population.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Endothelial microparticles interact with and support the proliferation of T cells.
TRO19622 Promotes Myelin Repair in a rat Model of Demyelination.
Simvastatin in patients with progressive multiple sclerosis.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.

Pages